Bartel D, Bonertz A, Hartenstein D, Kaul S, Lauer I, Reeb C et al. Allergen-specific immunotherapy and evidence: A European regulatory perspective. Allergologie select 2023;7:198-210

Biermann J, Merk HF, Wehrmann W, Klimek L, Wasem J. Allergische Erkrankungen der Atemwege – Ergebnisse einer umfassenden Patientenkohorte in der deutschen gesetzlichen Krankenversicherung. Allergo J 2013;22:366-73

Brans R. Eingeschränkte Verfügbarkeit von Epikutantestsubstanzen – Aktuelle Lage und neue Möglichkeiten zur Verbesserung der Versorgung. Dermatol Beruf Umwelt 2024;72:188-91

Burbach GJ, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S et al. Allergy. 2009;64:1507-15

CMDh Guideline Recommendation on common regulatory approaches for allergen products (CMDh/399/2019)

Deutsches Arzneimittelgesetz, Vollzitat: Gesetz über den Verkehr mit Arzneimitteln (Arzneimittelgesetz- AMG) neugefasst durch Bekanntmachung vom 12.12.2005 (BGBl. I S. 3394); zuletzt geändert am 23.10.2024

Draft Guideline on Allergen Product Development for Immunotherapy and Allergy Diagnosis in Moderate to Low-Sized Study Populations (EMA/CHMP/72790/2024)

EMA. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Common technical document for the registration of pharmaceuticals for human use: organisation of common technical document, 2004 (CPMP/ICH/2887/99)

EMA. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Guideline on allergen products: production and quality issues, 2007 (EMEA/ CHMP/BWP/ 304831/2007)

EMA. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Guideline on clinical evaluation of diagnostic agents, 2009 (CPMP/ EWP/1119/98/Rev. 1)

European Directorate for the Quality of Medicines (EDQM). Monograph: Allergen Products – Producta Allergenica 01/2010:1063. In: Council of Europe (ed.). European Pharmacopoeia, Strasbourg, ed. 11; 2025

Heinzerling LM, Burbach GJ, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S et al. GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy. 2009;64:1498-506

Heinzerling L, Frew AJ, Bindslev-Jensen C, et al. Standard skin prick testing and sensitization to inhalant allergens across Europea survey from the GALEN network. Allergy. 2005;60:1287-300

Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice. Contact Dermatitis. 2015;73:195-221

John SM, Bonertz A, Zimmer J, Aerts O, Bauer A, Bova M et al. Severely compromised supply of patch test allergens in Europe hampers adequate diagnosis of occupational and non-occupational contact allergy. A European Society of Contact Dermatitis (ESCD), European Academy of Allergy and Clinical Immunology (EAACI), European Academy of Dermatology and Venereology (EADV) task forces ‚Contact Dermatitis‘ and ‚Occupational Skin Disease‘ position paper Contact Dermatitis. 2024;91:91-103

Kaul S, Zimmer J, Dehus O, Costanzo A, Daas A, Buchheit KH et al. Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1. Allergy. 2016;71:1414-24

Klimek L, Werfel T, Vogelberg C, Jung K. Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written. Allergo J Int 2015;24:84-93

Mahler V, Nast A, Bauer A, Becker D, Brasch J, Breuer K et al. S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1. Journal der Deutschen Dermatologischen Gesellschaft. J Dtsch Dermatol Ges. 2019;17:1076-93

Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69:1008-25

Pfaar O, Hamelmann E, Taube C, Wagenmann M. DGAKI und PEI im Dialog 2023: Diagnostika und Allergen-Immuntherapie. Allergologie. 2023;46:818-25

Preisser AM, Koschel D, Merget R, Nowak D, Raulf M, Heidrich J. Workplace-related inhalation test - Specific inhalation challenge: S2k Guideline of the German Society for Occupational and Environmental Medicine e.V. (DGAUM), the German Society for Pneumology and Respiratory Medicine e.V. (DGP) and the German Society for Allergology and Clinical Immunology e.V. (DGAKI). Allergol Select 2021;5:315-34

Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW et al. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Laryngorhinootologie. 2003;82:183-8

Richtlinie 2001/83/EG des Europäischen Parlaments und des Rates vom 6. November 2001 zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel; ABl. L 311 vom 28.11.2001, S. 67ff, zuletzt geändert durch Verordnung (EU) 2023/1182 des Europäischen Parlaments und des Rates vom 14. Juni 2023

Rueff F, Bergmann KC, Brockow K, Fuchs T, Grübl A, Jung K et al. Hauttests zur Diagnostik von allergischen Soforttypreaktionen. Leitlinie der Deutschen Gesellschaft für Allergologie und klinischen Immunologie (DGAKI). Allergo J 2010;19:402-15

van Kampen V, de Blay F, Folletti I, Kobierski P, Moscato G, Olivieri M et al. Evaluation of commercial skin prick test solutions for selected occupational allergens. Allergy. 2013;68:651-8

van Kampen V, de Blay F, Folletti I, Kobierski P, Moscato G, Olivieri M et al. EAACI position paper: skin prick testing in the diagnosis of occupational type I allergies. Allergy. 2013;68:580-4

Zimmer J, Mahler V. Regulatory framework for development and marketing authorization of allergen products for diagnosis of rare type I and type IV allergies: The current status. Allergol Select. 2024;8:212-9

Zimmer J, Schmidt S, Kaul S, et al. Standardisation of allergen products: 4. Validation of a candidate European Pharmacopoeia standard method for quantification of major grass pollen allergen Phl p 5. Allergy. 2021;77:633-42